Cargando…
Coexistence of Congenital Adrenal Hyperplasia and Autoimmune Addison's Disease
Background: Underlying causes of adrenal insufficiency include congenital adrenal hyperplasia (CAH) and autoimmune adrenocortical destruction leading to autoimmune Addison's disease (AAD). Here, we report a patient with a homozygous stop-gain mutation in 3β-hydroxysteroid dehydrogenase type 2 (...
Autores principales: | Aslaksen, Sigrid, Methlie, Paal, Vigeland, Magnus D., Jøssang, Dag E., Wolff, Anette B., Sheng, Ying, Oftedal, Bergithe E., Skinningsrud, Beate, Undlien, Dag E., Selmer, Kaja K., Husebye, Eystein S., Bratland, Eirik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776599/ https://www.ncbi.nlm.nih.gov/pubmed/31611844 http://dx.doi.org/10.3389/fendo.2019.00648 |
Ejemplares similares
-
Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease
por: Aslaksen, Sigrid, et al.
Publicado: (2019) -
The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease
por: Wolff, Anette Boe, et al.
Publicado: (2021) -
Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia
por: Brønstad, Ingeborg, et al.
Publicado: (2014) -
21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison’s Disease Are Restricted by HLA-A2 and HLA-C7 Molecules
por: Hellesen, Alexander, et al.
Publicado: (2021) -
Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison’s Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2021)